Over 300 studies during the last five years have used saliva as a diagnostic medium to measure free hormone levels. Ninety to ninety-nine percent of steroid hormones are bound to carrier proteins (e.g. cortisol-binding globulin, sex-hormone-binding globulin, albumin), rendering them unavailable to target tissues. When released from their binding proteins, these small lipophilic molecules freely diffuse into tissues, including the salivary gland. The steroids measured in saliva are estrogens, progesterone, testosterone, DHEAS and cortisol.

Anderson Compounding Pharmacy is proud to exclusively utilize ZRT Laboratory for all salivary hormone testing. ZRT is unique as the only lab that does extracted saliva testing. During this process, interfering molecules in the saliva are removed, allowing for reproducible results with minimal interference from contaminants. For low-level hormones such as estradiol that require very sensitive testing methods, direct assay methods show decreased sensitivity. ZRT’s extraction process concentrates the sample for improved sensitivity, and it removes potentially interfering compounds for the highest level of accuracy and precision.

  • Saliva measures the bioavailable fraction of steroid hormones, using the salivary gland as a semipermeable membrane to assess what is available to the tissues.
  • Optimal collection time is possible, since testing is done by the patient at home.
  • Saliva can assess individuals using topical hormone supplementation.
  • The painless and needle-free procedure is especially important when collecting cortisol, which may be altered by the fear of a serum blood draw.
  • Hormones are stable in saliva at room temperature for up to three weeks, allowing worldwide shipment.
  • Cost effective — less expensive than conventional serum testing.

Saliva testing can help providers:

  • Identify hormone imbalances prior to the appearance of patient signs/symptoms
  • Identify hormone imbalances associated with symptoms
  • Establish hormone baselines prior to surgery or beginning therapy
  • Monitor hormone levels when supplementation is used, allowing for individualized hormone dosing
  • Track patient symptoms and hormone levels with comparative history reports provided with follow-up testing

With 20 years of experience and results from over 8 million tests, ZRT is a CLIA certified diagnostic laboratory and leader in innovative, safe, and meaningful hormone and wellness testing that assist health care providers in making informed treatment decisions.

  1. Bolaji II, Tallon DF, O’Dwyer E, Fottrell PF. Assessment of bioavailability of oral micronized progesterone using a salivary progesterone enzymeimmunoassay. Gynecol Endocrinol. 1993 Jun;7(2)101-10.
  2. Boothby LA, Doering PL, Kipersztok S. Bioidentical hormone therapy. Menopause. 2004 May-Jun;11(3):356-67.
  3. Calixto C, Martinez FE, Jorge SM, Moreira AC, Martinelli CE, Correlation between plasma and salivary cortisol levels in preterm infants. J Pediatr 2002;140(1):116-8.
  4. Cook, CJ. Rapid noninvasive measurement of hormones in transdermal exudate and saliva. Physiol Behav. 2002 Feb 1-15;75(1-2):169-81.
  5. Ellison PT. Measurements of Salivary Progesterone. Ann N Y Acad Sci. 1993 Sep. 20; 694:161-76.
  6. Finn MM, Gosling JP, Tallon DF, Baynes S, Meehan FP, Fottrell PF. The frequency of salivary progesterone sampling and diagnosis of luteal phase insufficiency. Gynecology Endocrinol. 1992 Jun;6(2):127-34.
  7. Gann PH, Giovanazzi S, Van Horn L, Branning A, Chatterton RT Jr. Saliva as a medium for investigating intra-and interindividual differences in sex hormone levels in premenopausal women.
    Cancer Epidemiol Biomarkers Prev 2001; 10(1):59-64.
  8. Gozansky WS, Lynn JS, Laudenslager ML, Kohrt WM. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic-pituitary-adrenal axis activity.
    Clin Endocrinol (Oxf) 2005; 63(3):336-41.
  9. Grossi G, Perski A, Ekstedt M, Johansson T, Lindstrom M, Holm K. The morning salivary cortisol response in burnout. J Psychosom Res 2005; 59(2):103-11.
  10. Heine RP, McGregor JA, Goodwin TM, Artal R, Hayashi RH, Robertson PA, Varner MW. Serial salivary estriol to detect an increased risk of preterm birth. Obstet Gynecol 2000; 96(4):490-7.
  11. Hirschman JD, Kresge JA. Synthesis of a symposium: innovative non- or minimally invasive technologies for monitoring health and nutritional status in mothers and young children. J Nutr. 2001 May;131(5):1643S-5S.
  12. Hofman LF. Human saliva as a diagnostic specimen. J Nutr 2001; 131(5):1621S-5S.
  13. Ishikawa M, Sengoku K, Tamate K, Takaoka Y, Kane M, Fottrell PF. The clinical usefulness of salivary progesterone measurement for the evaluation of the corpus luteum function. Gynecol Obstet Invest 2002; 53(1):32-7.
  14. Kivlighan KT, Granger DA, Schwartz EB, Nelson V, Curran M, Shirtcliff EA. Quantifying blood leakage into the oral mucosa and its effects on the measurement of cortisol, dehydroepiandrosterone, and testosterone in saliva. Horm Behav 2004; 46(1):39-46.
  15. Kumar AM, Solano MP, Fernandez JB, Kumar M. Adrenocortical response to ovine corticotropin-releasing hormone in young men: cortisol measurement in matched samples of saliva and plasma. Horm Res 2005; 64(2):55-60.
  16. Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999; 94(2):225-8.
  17. Lipson SF, Ellison PT. Reference values for luteal progesterone measured by salivary radioimmunoassay. Fertil Steril 1994; 61(3):448-54.
  18. Lipson SF, Ellison PT. Normative study of age variation in salivary progesterone profiles. J Biosoc Sci. 1992 Apr;24(2):233-44.
  19. McLean SA, Williams DA, Harris RE, Kop WJ, Groner KH, Ambrose K, Lyden AK, Gracely RH, Crofford LJ, Geisser ME, Sen A, Biswas P, Clauw DJ. Momentary relationship between cortisol secretion and symptoms in patients with fibromyalgia. Arthritis Rheum 2005; 52(11):3660-9.
  20. O’Leary P, Feddema P, Chan K, Taranto M, Smith M, Evans S. Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre- and postmenopausal women. Clin Endocrinol (Oxf) 2000; 53(5):615-20.
  21. Papanicolaou DA, Mullen N, Kyrou I, Nieman LK. Night time salivary cortisol: a useful test for the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 2002; 87(10):4515-21.
  22. Patel RS, Wallace AM, Hinnie J, McGarry GW. Preliminary results of a pilot study investigating the potential of salivary cortisol measurements to detect occult adrenal suppression secondary to steroid nose drops. Clin Otolaryngol Allied Sci 2001; 26(3):231-4.
  23. Riad-Fahmy D, Read GF, Walker RF. Salivary steroid assays for assessing variation in endocrine activity. J Steroid Biochem 1983; 19(1):265-272.
  24. Rilling JK, Worthman CM, Campbell BC, Stallings JF, Mbizva M. Ratios of plasma and salivary testosterone throughout puberty: production versus bioavailability. Steroids. 1996 June;61(6):374-8
  25. Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry 2004; 184:136-41.
  26. Sefton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000 Jun 21; 92(12):994-1000.
  27. Shirtcliff EA, Granger DA, Schwartz EB, Curran MJ, Booth A, Overman WH. Assessing estradiol in biobehavioral studies using saliva and blood spots: simple radioimmunoassay protocols, reliability, and comparative validity. Horm Behav 2000; 38(2):137-47.
  28. Tabak LA. A revolution in Biomedical Assessment: The Development of Salivary Diagnostics. J Dent Educ. 2001 Dec;65(12):1335-9.
  29. Vining RF, McGinley RA. Hormones in saliva. CRC Crit Rev Clin Lab Sci 1986; 23(2):95-146.
  30. Vining RF, McGinley RA. The measurement of hormones in saliva: possibilities and pitfalls. J Steroid Biochem 1987; 27(1-3):81-94.
  31. Wong V, Yan T, Donald A, McLean M. Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clin Endocrinol (Oxf) 2004; 61(1):131-7.
  32. Zava D. Saliva hormone testing. Townsend Letter for Doctors & Patients 2004; January:120-4